The Clinicopathological and Prognostic Significance of HER2-Low Breast Cancer: A Comparative Analysis Between HER2-Low and HER2-Zero Subtypes.
Nishimura R, Fujiki Y, Taira T, Miyaki T, Kanemitsu S, Yotsumoto D, Teraoka M, Kawano J, Gondo N, Mitsueda R, Baba S, Ohi Y, Rai Y, Sagara Y, Sagara Y.
Nishimura R, et al. Among authors: fujiki y.
Clin Breast Cancer. 2024 Jul;24(5):431-438. doi: 10.1016/j.clbc.2024.02.013. Epub 2024 Feb 22.
Clin Breast Cancer. 2024.
PMID: 38472058